Rhumbline Advisers Decreases Position in Varex Imaging Co. (NASDAQ:VREX)

Rhumbline Advisers decreased its position in shares of Varex Imaging Co. (NASDAQ:VREX) by 3.5% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 129,249 shares of the company’s stock after selling 4,717 shares during the quarter. Rhumbline Advisers owned 0.32% of Varex Imaging worth $1,904,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in VREX. Innealta Capital LLC bought a new stake in Varex Imaging during the second quarter valued at approximately $26,000. Quest Partners LLC bought a new stake in shares of Varex Imaging during the 4th quarter valued at $30,000. Pacific Center for Financial Services purchased a new stake in shares of Varex Imaging in the 1st quarter worth $94,000. Inspire Advisors LLC bought a new position in Varex Imaging in the 1st quarter worth $184,000. Finally, Price T Rowe Associates Inc. MD purchased a new position in Varex Imaging during the first quarter valued at $207,000.

Insiders Place Their Bets

In other news, CFO Shubham Maheshwari bought 10,000 shares of the stock in a transaction dated Monday, August 12th. The stock was purchased at an average cost of $10.82 per share, for a total transaction of $108,200.00. Following the transaction, the chief financial officer now owns 56,063 shares of the company’s stock, valued at $606,601.66. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. In related news, SVP Kimberley E. Honeysett sold 2,578 shares of the firm’s stock in a transaction that occurred on Tuesday, August 20th. The stock was sold at an average price of $12.53, for a total transaction of $32,302.34. Following the completion of the sale, the senior vice president now directly owns 275 shares of the company’s stock, valued at approximately $3,445.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Shubham Maheshwari acquired 10,000 shares of the company’s stock in a transaction that occurred on Monday, August 12th. The shares were acquired at an average price of $10.82 per share, with a total value of $108,200.00. Following the acquisition, the chief financial officer now owns 56,063 shares in the company, valued at $606,601.66. The disclosure for this purchase can be found here. Corporate insiders own 5.20% of the company’s stock.

Varex Imaging Trading Down 0.8 %

Varex Imaging stock opened at $10.79 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.34 and a quick ratio of 1.89. The firm’s 50 day moving average price is $12.56 and its 200-day moving average price is $14.88. Varex Imaging Co. has a 1 year low of $10.19 and a 1 year high of $21.50. The stock has a market cap of $441.31 million, a P/E ratio of 12.12 and a beta of 0.56.

Varex Imaging (NASDAQ:VREX) last announced its quarterly earnings results on Thursday, August 1st. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.19 by ($0.05). The company had revenue of $209.00 million during the quarter, compared to analysts’ expectations of $209.50 million. Varex Imaging had a return on equity of 6.11% and a net margin of 4.11%. The firm’s revenue for the quarter was down 10.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.37 EPS. On average, equities analysts predict that Varex Imaging Co. will post 0.46 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, B. Riley started coverage on Varex Imaging in a research report on Friday, August 23rd. They set a “buy” rating and a $21.00 price objective on the stock.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.